Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions-Reference-Cited by-同舟云学术

Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions

Published:2017-08 Issue:8 Volume:18 Page:580-589
ISSN:1558-2027
Container-title:Journal of Cardiovascular Medicine
language:en
Short-container-title:Journal of Cardiovascular Medicine

Author:

De Luca Leonardo,Musumeci Giuseppe,Leonardi Sergio,Gonzini Lucio,Cavallini Claudio,Calabrò Paolo,Mauro Ciro,Cacciavillani Luisa,Savonitto Stefano,De Servi Stefano

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference25 articles.

1. 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

2. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

3. Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry

4. Population Trends in Percutaneous Coronary Intervention

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial;Circulation;2024-04-16

2. Safety of cangrelor and transition to oral P2Y12 inhibitors in patients undergoing percutaneous coronary intervention: the ARCANGELO study;European Heart Journal Open;2023-07

3. Use of cangrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Study design and interim analysis of the ARCANGELO study;Clinical Cardiology;2022-06-22

4. Postprocedure Anticoagulation in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention;JACC: Cardiovascular Interventions;2022-02

5. Periprocedural Myocardial Injury in High‐Risk Patients With NSTEMI Pretreated With Ticagrelor for Less or More Than 6 Hours Before PCI;The Journal of Clinical Pharmacology;2022-01-03